S. Manuso James - Jun 11, 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
Director
Signature
/s/ Amy Rabourn, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Jun 11, 2024
Transactions value $
$0
Form type
4
Date filed
6/13/2024, 05:28 PM
Previous filing
Jan 3, 2024
Next filing
Oct 22, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +41.1K +45.26% $0.00 132K Jun 11, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Stock Option (Right to Buy) Award $0 +35.2K $0.00 35.2K Jun 11, 2024 Common Stock 35.2K $1.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
F2 The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney